This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by David-Dufilho, M. Articles by Devynck, M. A. Search for Related Content PubMed PubMed Citation Articles by David-Dufilho, M. Articles by Devynck, M. A.

Hypertension, Vol 19, 167-174, Copyright © 1992 by American Heart Association

ARTICLES

Control of the erythrocyte free Ca2+ concentration in essential hypertension

M David-Dufilho, C Astarie, MG Pernollet, M Del Pino, J Levenson, A Simon and MA Devynck
Department of Pharmacology, CNRS 16167, Necker Medical School, Paris, France.

Since Ca2+ ions seem to directly participate in the control of erythrocyte membrane structure and deformability and because cell Ca2+ metabolism has been repeatedly proposed to be modified in hypertension, the intracellular calcium ion concentration ([Ca2+]i) was investigated in red blood cells from hypertensive and normotensive subjects. [Ca2+]i was measured by using the fluorescent Ca2+ chelator fura-2. Red blood cell [Ca2+]i was increased in hypertensive compared with normotensive subjects in the whole population and further increased when hypertensive were compared with age-matched normotensive subjects. An inverse relation between age and [Ca2+]i was observed when calculated with blood pressure adjusted. In hypertensive patients, high [Ca2+]i values were associated with a reduced erythrocyte deformability. The initial rate of 45Ca2+ uptake did not differ between the two blood pressure groups. Similarly, when the extracellular Ca2+ concentration was elevated from 1 to 2 mmol/l, [Ca2+]i increased by 16 +/- 4% (p less than 0.03) in red blood cells from both groups, thus maintaining a significant difference between hypertensive and normotensive subjects. Under these conditions, the addition of 10(-7) mol/l nicardipine, a dihydropyridine Ca2+ antagonist, decreased [Ca2+]i by 15 +/- 4% (p less than 0.05) and 7 +/- 5% in erythrocytes from hypertensive and normotensive subjects, respectively, thereby reducing the difference in [Ca2+]i observed between these two groups. This nicardipine effect was positively correlated to the initial [Ca2+]i. In the presence of 5 mumol/l W7, a calmodulin antagonist, [Ca2+]i increased significantly only in erythrocytes from hypertensive patients (26 +/- 6%, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				A. Aneja, F. El-Atat, S. I. McFarlane, and J. R. Sowers Hypertension and Obesity Recent Prog. Horm. Res., January 1, 2004; 59(1): 169 - 205. [Abstract] [Full Text]

				D. A. Andrews, L. Yang, and P. S. Low Phorbol ester stimulates a protein kinase C-mediated agatoxin-TK-sensitive calcium permeability pathway in human red blood cells Blood, October 16, 2002; 100(9): 3392 - 3399. [Abstract] [Full Text] [PDF]

				I. Gabriely, X. M. Yang, J. A. Cases, X. H. Ma, L. Rossetti, and N. Barzilai Hyperglycemia modulates angiotensinogen gene expression Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2001; 281(3): R795 - R802. [Abstract] [Full Text] [PDF]

				A. L. Hadengue, M. Del-Pino, A. Simon, and J. Levenson Erythrocyte Disaggregation Shear Stress, Sialic Acid, and Cell Aging in Humans Hypertension, August 1, 1998; 32(2): 324 - 330. [Abstract] [Full Text] [PDF]